0001140361-23-021502.txt : 20230428 0001140361-23-021502.hdr.sgml : 20230428 20230428160429 ACCESSION NUMBER: 0001140361-23-021502 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230427 FILED AS OF DATE: 20230428 DATE AS OF CHANGE: 20230428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wotton Paul K CENTRAL INDEX KEY: 0001300997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 23865815 MAIL ADDRESS: STREET 1: C/O ANTARES PHARMA, INC. STREET 2: 707 EAGLEVIEW BOULEVARD, SUITE 414 CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 form4.xml X0407 4 2023-04-27 0000887359 Vericel Corp VCEL 0001300997 Wotton Paul K C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true false Common Stock 2023-04-27 4 M 0 2600 A 31802 D Restricted Stock Unit 2023-04-27 4 M 0 2600 0 D Common Stock 2600 0 D The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 27, 2022. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022. No expiration date for this type of award /s/ Sean Flynn, as Attorney-in-Fact for Paul Wotton 2023-04-28